ALB and Hypoalbuminemia: Chronic kidney disease (CKD) has emerged as a significant global health issue, affecting approximately 10% of the population worldwide, with cases spanning early to advanced stages of the disease, ranging from early to advanced stages of the disease (1, 2).One common complication in CKD is hypoalbuminemia, characterized by low serum albumin levels, which affects about 30% to 50% of patients, especially those in advanced stages (3).